OpenVSafe by OpenVAERS
Search V-safe

VK8-20783-42850

2 vaccinations 3 coded responses 14 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
410 / KY
Registered
2021-01-07
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-07
    Registered in v-safe
  2. 2021-01-07
    Dose 1 — Moderna
  3. 2021-01-07
    Survey response — day 0, dose 1
    MedDRA: Vision blurred — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Free text: Vision blurred slightly
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  5. 2021-01-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-23
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-01-30
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-02-03
    Dose 2 — Moderna
  10. 2021-02-03
    Survey response — day 0, dose 2
    MedDRA: Skin warm, Vision blurred — Feeling: Good · Fever
    Free text: Slight blurred vision, skin is warm
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness · Be unable to work
    Adult check-in
  12. 2021-02-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling · None
    Adult check-in
  13. 2021-02-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness · None
    Adult check-in
  14. 2021-02-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  15. 2021-02-12
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-02-19
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  17. 2022-02-05
    Survey response — 12 months, dose 2
    MedDRA: Basal cell carcinoma, Neuroma — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: I got Morton's Neuroma in foot and Basil Cell cancer on forehead
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-02-05
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  19. 2022-02-10
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-01-07Moderna
22021-02-03Moderna

Call center

ReportedOutcomeVAERS-related outcome
2022-02-05 Successful
2022-02-10
Participant prefers to complete VAERS report online

Free text

Release 1 — day 0, dose 1

2021-01-07

Systemic reaction (other): Vision blurred slightly

Release 3 — day 0, dose 2

2021-02-03

Systemic reaction (other): Slight blurred vision, skin is warm

Release 11 — 12 months, dose 2

2022-02-05

Symptoms: I got Morton's Neuroma in foot and Basil Cell cancer on forehead

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBasal cell carcinoma · · ✓
SDNeuroma · · ✓
SROSkin warm ✓ ✓ ✓
SROVision blurred ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release